Why restricted mean survival time methods are especially useful for non-inferiority trials. (2021)
Attributed to:
Design of Trials, Meta-analyses and observational studies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/17407745211045124
PubMed Identifier: 34553627
Publication URI: http://europepmc.org/abstract/MED/34553627
Type: Journal Article/Review
Volume: 18
Parent Publication: Clinical trials (London, England)
Issue: 6
ISSN: 1740-7745